The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Biopharmaceutical benchmarks 2006
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects
Brown, M. B., Martin, G. P., Jones, S. A., & Akomeah, F. K. (2006) · Drug Delivery · doi:10.1080/10717540500455975 · Cited by 688
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Butler, M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1980-8 · Cited by 469
Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Peng, Z. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1016 · Cited by 436
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi
Gerngross, T. U. (2004) · Nature Biotechnology · doi:10.1038/nbt1028 · Cited by 409
The humanization of N-glycosylation pathways in yeast
Wildt, S., & Gerngross, T. U. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1087 · Cited by 393
Recombinant protein therapeutics—success rates, market trends and values to 2010
Pavlou, A. K., & Reichert, J. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1204-1513 · Cited by 334
Aptamers—basic research, drug development, and clinical applications
Proske, D., Blank, M., Buhmann, R., & Resch, A. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0193-5 · Cited by 281
High-yield secretion of recombinant gelatins byPichia pastoris
Werten, M. W. T., van den Bosch, T. J., Wind, R. D., Mooibroek, H., & de Wolf, F. A. (1999) · Yeast · doi:10.1002/(sici)1097-0061(199908)15:11<1087::aid-yea436>3.0.co;2-f · Cited by 258
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Drug delivery in biotechnology: present and future
Orive, G., Hernández, R. M., Gascón, A. R., Domı́nguez-Gil, A., & Pedraz, J. L. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.007 · Cited by 223
Production of human monoclonal antibody in eggs of chimeric chickens
Zhu, L., van de Lavoir, M.-C., Albanese, J., Beenhouwer, D. O., Cardarelli, P. M., Cuison, S., Deng, D. F., Deshpande, S., Diamond, J. H., Green, L., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1132 · Cited by 222
Jarvis, D. L. (2003) · Virology · doi:10.1016/s0042-6822(03)00120-x · Cited by 199
Patton, J. S., Bukar, J., & Nagarajan, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00074-x · Cited by 193
Biopharmaceutical production in plants: problems, solutions and opportunities
Gomord, V., Chamberlain, P., Jefferis, R., & Faye, L. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.09.003 · Cited by 186
Yeast secretory expression of insulin precursors
Kjeldsen, T. (2000) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000402 · Cited by 176
Biopharmaceutical benchmarks—2003
Walsh, G. (2003) · Nature Biotechnology · doi:10.1038/nbt0803-865 · Cited by 162
Self-citationTherapeutic insulins and their large-scale manufacture
Walsh, G. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1809-x · Cited by 161
Self-citationThe therapeutic antibodies market to 2008
Pavlou, A. K., & Belsey, M. J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.007 · Cited by 153
Artificial, non-antibody binding proteins for pharmaceutical and industrial applications
Hey, T., Fiedler, E., Rudolph, R., & Fiedler, M. R. M. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.07.007 · Cited by 136
Gendicine: The First Commercial Gene Therapy Product; Chinese Translation of Editorial
Wilson, J. M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1014 · Cited by 130
Micelle-Associated Protein in Epoetin Formulations: A Risk Factor for Immunogenicity?
Hermeling, S., Schellekens, H., Crommelin, D. J. A., & Jiskoot, W. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008034.61317.02 · Cited by 124
RNAi: a novel antisense technology and its therapeutic potential.
Dallas, A., & Vlassov, A. V. (2006) · PubMed · Cited by 91
Chen, M., Liu, X., Wang, Z., Song, J. K., Qi, Q., & Wang, P. G. (2004) · Medicinal Research Reviews · doi:10.1002/med.20022 · Cited by 72
Interaction of Polysorbate 80 with Erythropoietin: A Case Study in Protein–Surfactant Interactions
Villalobos, A. P., Gunturi, S. R., & Heavner, G. A. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5356-7 · Cited by 56
Khan, A. U. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.023 · Cited by 54
Vidal, L., Blagden, S. P., Attard, G., & Bono, J. S. D. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.029 · Cited by 51
Competitive bioreactor hens on the horizon
IVARIE, R. D. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.01.004 · Cited by 50
RNA interference: potential therapeutic targets
Jana, S., Chakraborty, C., Nandi, S., & Deb, J. K. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1732-1 · Cited by 46
Lim, L. C. (2005) · Hematology · doi:10.1080/10245330400026154 · Cited by 20
Hermeling, S., Jiskoot, W., Crommelin, D. J. A., & Schellekens, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9573-5 · Cited by 13
Cited by
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
Hawe, A., Sutter, M., & Jiskoot, W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9516-9 · Cited by 1,199
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Self-citationBiopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
Self-citationBiopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 756
Self-citationDendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
Metadata
- Authors
- Walsh, G.
- Venue
- Nature Biotechnology
- Published
- 2006-07
- Volume
- 24
- Issue
- 7
- Pages
- 769-776
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1508509739
- Cited by
- 359
- References
- 36
- FWCI
- 97.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.